-
1
-
-
77956262693
-
Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): A phase 3, open-label, randomised controlled trial
-
20728210 10.1016/S0140-6736(10)61121-X 1:CAS:528:DC%2BC3cXhtVymt7zO
-
Bang YJ, Van Cutsem E, Feyereislova A, Chung HC, Shen L, Sawaki A, et al. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial. Lancet. 2010;376:687-97.
-
(2010)
Lancet
, vol.376
, pp. 687-697
-
-
Bang, Y.J.1
Van Cutsem, E.2
Feyereislova, A.3
Chung, H.C.4
Shen, L.5
Sawaki, A.6
-
2
-
-
77949884456
-
Targeted HER2 treatment in advanced gastric cancer
-
20185938 10.1159/000288295
-
Jørgensen JT. Targeted HER2 treatment in advanced gastric cancer. Oncology. 2010;78:26-33.
-
(2010)
Oncology
, vol.78
, pp. 26-33
-
-
Jørgensen, J.T.1
-
3
-
-
44249092320
-
Assessment of a HER2 scoring system for gastric cancer: Results from a validation study
-
DOI 10.1111/j.1365-2559.2008.03028.x
-
Hofmann M, Stoss O, Shi D, Büttner R, van de Vijver M, Kim W, et al. Assessment of a HER2 scoring system for gastric cancer: results from a validation study. Histopathology. 2008;52:797-805. (Pubitemid 351724903)
-
(2008)
Histopathology
, vol.52
, Issue.7
, pp. 797-805
-
-
Hofmann, M.1
Stoss, O.2
Shi, D.3
Buttner, R.4
Van De Vijver, M.5
Kim, W.6
Ochiai, A.7
Ruschoff, J.8
Henkel, T.9
-
4
-
-
33748154637
-
HER-2/neu amplification is an independent prognostic factor in gastric cancer
-
DOI 10.1007/s10620-005-9057-1
-
Park DI, Yun JW, Park JH, Oh SJ, Kim HJ, Cho YK, et al. HER-2/neu amplification is an independent prognostic factor in gastric cancer. Dig Dis Sci. 2006;51:1371-9. (Pubitemid 44315804)
-
(2006)
Digestive Diseases and Sciences
, vol.51
, Issue.8
, pp. 1371-1379
-
-
Park, D.I.1
Yun, J.W.2
Park, J.H.3
Oh, S.J.4
Kim, H.J.5
Cho, Y.K.6
Sohn, C.I.7
Jeon, W.K.8
Kim, B.I.9
Yoo, C.H.10
Son, B.H.11
Cho, E.Y.12
Chae, S.W.13
Kim, E.-J.14
Sohn, J.H.15
Ryu, S.H.16
Sepulveda, A.R.17
-
5
-
-
70349327606
-
Comparative study on overexpression of HER2/neu and HER3 in gastric cancer
-
19636613 10.1007/s00268-009-0142-z
-
Zhang XL, Yang YS, Xu DP, Qu JH, Guo MZ, Gong Y, et al. Comparative study on overexpression of HER2/neu and HER3 in gastric cancer. World J Surg. 2009;33:2112-8.
-
(2009)
World J Surg
, vol.33
, pp. 2112-2118
-
-
Zhang, X.L.1
Yang, Y.S.2
Xu, D.P.3
Qu, J.H.4
Guo, M.Z.5
Gong, Y.6
-
6
-
-
0027436752
-
Overexpression of c-erbB-2 protein in gastric cancer: Its correlation with long-term survival of patients
-
DOI 10.1002/1097-0142(19931201)72:11<3179::AID-CNCR2820721108>3.0. CO;2-#
-
Uchino S, Tsuda H, Maruyama K, Kinoshita T, Sasako M, Saito T, et al. Overexpression of c-erbB-2 protein in gastric cancer. Its correlation with long-term survival of patients. Cancer. 1993;72:3179-84. (Pubitemid 23356757)
-
(1993)
Cancer
, vol.72
, Issue.11
, pp. 3179-3184
-
-
Uchino, S.1
Tsuda, H.2
Maruyama, K.3
Kinoshita, T.4
Sasako, M.5
Saito, T.6
Kobayashi, M.7
Hirohashi, S.8
-
7
-
-
0033135820
-
The prognostic significance of amplification and overexpression of c- met and c-erb B-2 in human gastric carcinomas
-
DOI 10.1002/(SICI)1097-0142(19990501)85:9<1894::AID-CNCR3>3.0.CO;2- J
-
Nakajima M, Sawada H, Yamada Y, Watanabe A, Tatsumi M, Yamashita J, et al. The prognostic significance of amplification and overexpression of c-met and c-erb B-2 in human gastric carcinomas. Cancer. 1999;85:1894-902. (Pubitemid 29202761)
-
(1999)
Cancer
, vol.85
, Issue.9
, pp. 1894-1902
-
-
Nakajima, M.1
Sawada, H.2
Yamada, Y.3
Watanabe, A.4
Tatsumi, M.5
Yamashita, J.6
Matsuda, M.7
Sakaguchi, T.8
Hirao, T.9
Nakano, H.10
-
8
-
-
0034118639
-
C-erbB-2 is of independent prognostic relevance in gastric cancer and is associated with the expression of tumor-associated protease systems
-
Allgayer H, Babic R, Gruetzner KU, Tarabichi A, Schildberg FW, Heiss MM. c-erbB-2 is of independent prognostic relevance in gastric cancer and is associated with the expression of tumor-associated protease systems. J Clin Oncol. 2000;18:2201-9. (Pubitemid 30350211)
-
(2000)
Journal of Clinical Oncology
, vol.18
, Issue.11
, pp. 2201-2209
-
-
Allgayer, H.1
Babic, R.2
Gruetzner, K.U.3
Tarabichi, A.4
Schildberg, F.W.5
Heiss, M.M.6
-
9
-
-
0037795412
-
Clinical significance of the epidermal growth factor receptor and HER2 receptor in resectable gastric cancer
-
DOI 10.1245/ASO.2003.05.010
-
García I, Vizoso F, Martín A, Sanz L, Abdel-Lah O, Raigoso P, et al. Clinical significance of the epidermal growth factor receptor and HER2 receptor in resectable gastric cancer. Ann Surg Oncol. 2003;10:234-41. (Pubitemid 40486955)
-
(2003)
Annals of Surgical Oncology
, vol.10
, Issue.3
, pp. 234-241
-
-
Garcia, I.1
Vizoso, F.2
Martin, A.3
Sanz, L.4
Abdel-Lah, O.5
Raigoso, P.6
Garcia-Muniz, J.L.7
-
10
-
-
20044372721
-
Amplification of HER-2 in gastric carcinoma: Association with Topoisomerase II gene amplification, intestinal type, poor prognosis and sensitivity to trastuzumab
-
DOI 10.1093/annonc/mdi064
-
Tanner M, Hollmén M, Junttila TT, Kapanen AI, Tommola S, Soini Y, et al. Amplification of HER-2 in gastric carcinoma: association with Topoisomerase IIalpha gene amplification, intestinal type, poor prognosis and sensitivity to trastuzumab. Ann Oncol. 2005;16:273-8. (Pubitemid 40309309)
-
(2005)
Annals of Oncology
, vol.16
, Issue.2
, pp. 273-278
-
-
Tanner, M.1
Hollmen, M.2
Junttila, T.T.3
Kapanen, A.I.4
Tommola, S.5
Soini, Y.6
Helin, H.7
Salo, J.8
Joensuu, H.9
Sihvo, E.10
Elenius, K.11
Isola, J.12
-
11
-
-
0025974889
-
Evaluation of immunoreactivity for erbB-2 protein as a marker of poor short term prognosis in gastric cancer
-
1670998 1:STN:280:DyaK3M7gsFKqsw%3D%3D
-
Yonemura Y, Ninomiya I, Yamaguchi A, Fushida S, Kimura H, Ohoyama S, et al. Evaluation of immunoreactivity for erbB-2 protein as a marker of poor short term prognosis in gastric cancer. Cancer Res. 1991;51:1034-8.
-
(1991)
Cancer Res
, vol.51
, pp. 1034-1038
-
-
Yonemura, Y.1
Ninomiya, I.2
Yamaguchi, A.3
Fushida, S.4
Kimura, H.5
Ohoyama, S.6
-
12
-
-
0036817076
-
C-erb B-2 expression is associated with tumor location and venous invasion and influences survival of patients with gastric carcinoma
-
Pinto-de-Sousa J, David L, Almeida R, Leitão D, Preto JR, Seixas M, et al. c-erb B-2 expression is associated with tumor location and venous invasion and influences survival of patients with gastric carcinoma. Int J Surg Pathol. 2002;10:247-56. (Pubitemid 35461524)
-
(2002)
International Journal of Surgical Pathology
, vol.10
, Issue.4
, pp. 247-256
-
-
Pinto-de-Sousa, J.1
David, L.2
Almeida, R.3
Leitao, D.4
Preto, J.R.5
Seixas, M.6
Pimenta, A.7
-
13
-
-
34547838197
-
Evaluation of HER-2 gene status in gastric carcinoma using immunohistochemistry, fluorescence in situ hybridization, and real-time quantitative polymerase chain reaction
-
DOI 10.1016/j.humpath.2007.02.005, PII S0046817707000949
-
Kim MA, Jung EJ, Lee HS, Lee HE, Jeon YK, Yang HK, et al. Evaluation of HER-2 gene status in gastric carcinoma using immunohistochemistry, fluorescence in situ hybridization, and real-time quantitative polymerase chain reaction. Hum Pathol. 2007;38:1386-93. (Pubitemid 47247482)
-
(2007)
Human Pathology
, vol.38
, Issue.9
, pp. 1386-1393
-
-
Kim, M.A.1
Jung, E.J.2
Lee, H.S.3
Lee, H.E.4
Jeon, Y.K.5
Yang, H.-K.6
Kim, W.H.7
-
14
-
-
67349222954
-
HER-2 amplification is highly homogenous in gastric cancer
-
19269014 10.1016/j.humpath.2008.11.014 1:CAS:528:DC%2BD1MXmtFektb8%3D
-
Marx AH, Tharun L, Muth J, Dancau AM, Simon R, Yekebas E, et al. HER-2 amplification is highly homogenous in gastric cancer. Hum Pathol. 2009;40:769-77.
-
(2009)
Hum Pathol
, vol.40
, pp. 769-777
-
-
Marx, A.H.1
Tharun, L.2
Muth, J.3
Dancau, A.M.4
Simon, R.5
Yekebas, E.6
-
15
-
-
77749273477
-
HER2 expression in gastric cancer: Rare, heterogeneous and of no prognostic value - Conclusions from 924 cases of two independent series
-
20208134
-
Grabsch H, Sivakumar S, Gray S, Gabbert HE, Müller W. HER2 expression in gastric cancer: rare, heterogeneous and of no prognostic value - conclusions from 924 cases of two independent series. Cell Oncol. 2010;32:57-65.
-
(2010)
Cell Oncol
, vol.32
, pp. 57-65
-
-
Grabsch, H.1
Sivakumar, S.2
Gray, S.3
Gabbert, H.E.4
Müller, W.5
-
16
-
-
84872679323
-
HER2 Expression in gastric and gastroesophageal junction adenocarcinoma in a US population: Clinicopathologic analysis with proposed approach to HER2 assessment
-
Kunz PL, Mojtahed A, Fisher GA, Ford JM, Chang DT, Balise RR, et al. HER2 Expression in gastric and gastroesophageal junction adenocarcinoma in a US population: clinicopathologic analysis with proposed approach to HER2 assessment. Appl Immunohistochem Mol Morphol. 2011;40(36):9212-20.
-
(2011)
Appl Immunohistochem Mol Morphol.
, vol.40
, Issue.36
, pp. 9212-9220
-
-
Kunz, P.L.1
Mojtahed, A.2
Fisher, G.A.3
Ford, J.M.4
Chang, D.T.5
Balise, R.R.6
-
17
-
-
0038470907
-
Prognostic significance of p53, nm23, PCNA and c-erbB-2 in gastric cancer
-
DOI 10.1093/jjco/hyg039
-
Lee KE, Lee HJ, Kim YH, Yu HJ, Yang HK, Kim WH, et al. Prognostic significance of p53, nm23, PCNA and c-erbB-2 in gastric cancer. Jpn J Clin Oncol. 2003;33:173-9. (Pubitemid 43102860)
-
(2003)
Japanese Journal of Clinical Oncology
, vol.33
, Issue.4
, pp. 173-179
-
-
Lee, K.E.1
Lee, H.-J.2
Kim, Y.H.3
Yu, H.J.4
Yang, H.-K.5
Kim, W.-H.6
Lee, K.U.7
Choe, K.J.8
Kim, J.-P.9
-
18
-
-
69049087660
-
Overexpression of Grb2/HER2 signaling in Chinese gastric cancer: Their relationship with clinicopathological parameters and prognostic significance
-
19337752 10.1007/s00432-009-0574-8 1:CAS:528:DC%2BD1MXhtVSit7fF
-
Yu GZ, Chen Y, Wang JJ. Overexpression of Grb2/HER2 signaling in Chinese gastric cancer: their relationship with clinicopathological parameters and prognostic significance. J Cancer Res Clin Oncol. 2009;135:1331-9.
-
(2009)
J Cancer Res Clin Oncol
, vol.135
, pp. 1331-1339
-
-
Yu, G.Z.1
Chen, Y.2
Wang, J.J.3
-
19
-
-
59649084142
-
Association of ERBB2 gene status with histopathological parameters and disease-specific survival in gastric carcinoma patients
-
19156142 10.1038/sj.bjc.6604885 1:CAS:528:DC%2BD1MXhsFeksbc%3D
-
Barros-Silva JD, Leitão D, Afonso L, Vieira J, Dinis-Ribeiro M, Fragoso M, et al. Association of ERBB2 gene status with histopathological parameters and disease-specific survival in gastric carcinoma patients. Br J Cancer. 2009;100:487-93.
-
(2009)
Br J Cancer
, vol.100
, pp. 487-493
-
-
Barros-Silva, J.D.1
Leitão, D.2
Afonso, L.3
Vieira, J.4
Dinis-Ribeiro, M.5
Fragoso, M.6
-
20
-
-
49149123885
-
Clinicopathological and prognostic significance of mucin phenotype in gastric cancer
-
18521835 10.1002/jso.21093
-
Wakatsuki K, Yamada Y, Narikiyo M, Ueno M, Takayama T, Tamaki H, et al. Clinicopathological and prognostic significance of mucin phenotype in gastric cancer. J Surg Oncol. 2008;98:124-9.
-
(2008)
J Surg Oncol
, vol.98
, pp. 124-129
-
-
Wakatsuki, K.1
Yamada, Y.2
Narikiyo, M.3
Ueno, M.4
Takayama, T.5
Tamaki, H.6
-
21
-
-
0026483785
-
P53 point mutations in primary human gastric carcinomas
-
1429828 10.1007/BF01209657 1:CAS:528:DyaK2cXisVWntL8%3D
-
Yokozaki H, Kuniyasu H, Kitadai Y, Nishimura K, Todo H, Ayhan A, et al. p53 point mutations in primary human gastric carcinomas. J Cancer Res Clin Oncol. 1992;119:67-70.
-
(1992)
J Cancer Res Clin Oncol
, vol.119
, pp. 67-70
-
-
Yokozaki, H.1
Kuniyasu, H.2
Kitadai, Y.3
Nishimura, K.4
Todo, H.5
Ayhan, A.6
-
22
-
-
24644467632
-
waf1, HER-2/neu, and Ki67 proteins expression in gastric cancer: A clinicopathological and immunohistochemical study of 121 Arab patients
-
DOI 10.1002/jso.20324
-
Al-Moundhri MS, Nirmala V, Al-Hadabi I, Al-Mawaly K, Burney I, Al-Nabhani M, et al. The prognostic significance of p53, p27 kip1, p21 waf1, HER-2/neu, and Ki67 proteins expression in gastric cancer: a clinicopathological and immunohistochemical study of 121 Arab patients. J Surg Oncol. 2005;91:243-52. (Pubitemid 41266821)
-
(2005)
Journal of Surgical Oncology
, vol.91
, Issue.4
, pp. 243-252
-
-
Al-Moundhri, M.S.1
Nirmala, V.2
Al-Hadabi, I.3
Al-Mawaly, K.4
Burney, I.5
Al-Nabhani, M.6
Thomas, V.7
Ganguly, S.S.8
Grant, C.9
-
23
-
-
77956895978
-
HER2 diagnostics in gastric cancer-guideline validation and development of standardized immunohistochemical testing
-
20665045 10.1007/s00428-010-0952-2
-
Rüschoff J, Dietel M, Baretton G, Arbogast S, Walch A, Monges G, et al. HER2 diagnostics in gastric cancer-guideline validation and development of standardized immunohistochemical testing. Virchows Arch. 2010;457:299-307.
-
(2010)
Virchows Arch
, vol.457
, pp. 299-307
-
-
Rüschoff, J.1
Dietel, M.2
Baretton, G.3
Arbogast, S.4
Walch, A.5
Monges, G.6
-
24
-
-
0032990321
-
Application of tyramide signal amplification system to immunohistochemistry: A potent method to localize antigens that are not detectable by ordinary method
-
DOI 10.1046/j.1440-1827.1999.00875.x
-
Toda Y, Kono K, Abiru H, Kokuryo K, Endo M, Yaegashi H, et al. Application of tyramide signal amplification system to immunohistochemistry: a potent method to localize antigens that are not detectable by ordinary method. Pathol Int. 1999;49:479-83. (Pubitemid 29309683)
-
(1999)
Pathology International
, vol.49
, Issue.5
, pp. 479-483
-
-
Toda, Y.1
Kono, K.2
Abiru, H.3
Kokuryo, K.4
Endo, M.5
Yaegashi, H.6
Fukumoto, M.7
-
25
-
-
61549129034
-
Clinicopathologic and prognostic significance of overexpression of her-2/neu and p53 oncoproteins in gastric carcinoma using tissue microarray
-
Ismail HM, Moneer M, El-Baradie M, Khorshid O, Touny A. Clinicopathologic and prognostic significance of overexpression of her-2/neu and p53 oncoproteins in gastric carcinoma using tissue microarray. J Egypt Natl Cancer Inst. 2007;19:147-57.
-
(2007)
J Egypt Natl Cancer Inst
, vol.19
, pp. 147-157
-
-
Ismail, H.M.1
Moneer, M.2
El-Baradie, M.3
Khorshid, O.4
Touny, A.5
-
26
-
-
78049455776
-
Predictors of timing and patterns of recurrence after curative resection for gastric cancer
-
21063125 10.1159/000320691
-
Eom BW, Yoon H, Ryu KW, Lee JH, Cho SJ, Lee JY, et al. Predictors of timing and patterns of recurrence after curative resection for gastric cancer. Dig Surg. 2010;27:481-6.
-
(2010)
Dig Surg
, vol.27
, pp. 481-486
-
-
Eom, B.W.1
Yoon, H.2
Ryu, K.W.3
Lee, J.H.4
Cho, S.J.5
Lee, J.Y.6
-
27
-
-
77956945071
-
A study of HER2 gene amplification and protein expression in gastric cancer
-
20696687 10.1136/jcp.2010.076570
-
Yan B, Yau EX, Bte Omar SS, Ong CW, Pang B, Yeoh KG, et al. A study of HER2 gene amplification and protein expression in gastric cancer. J Clin Pathol. 2010;63:839-42.
-
(2010)
J Clin Pathol
, vol.63
, pp. 839-842
-
-
Yan, B.1
Yau, E.X.2
Bte Omar, S.S.3
Ong, C.W.4
Pang, B.5
Yeoh, K.G.6
-
28
-
-
79955928823
-
Clinicopathologic significance of HER-2/neu protein expression and gene amplification in gastric carcinoma
-
21472111 10.3748/wjg.v17.i11.1501 1:CAS:528:DC%2BC3MXkvFGqsrY%3D
-
Yan SY, Hu Y, Fan JG, Tao GQ, Lu YM, Cai X, et al. Clinicopathologic significance of HER-2/neu protein expression and gene amplification in gastric carcinoma. World J Gastroenterol. 2011;17:1501-6.
-
(2011)
World J Gastroenterol
, vol.17
, pp. 1501-1506
-
-
Yan, S.Y.1
Hu, Y.2
Fan, J.G.3
Tao, G.Q.4
Lu, Y.M.5
Cai, X.6
-
29
-
-
79958066203
-
Clinicopathologic characteristics of patients with stage III/IV (M(0)) advanced gastric cancer, according to HER2 status assessed by immunohistochemistry and fluorescence in situ hybridization
-
21532492 10.1097/PDM.0b013e3181fc02b7 1:CAS:528:DC%2BC3MXmtFyrsL0%3D
-
Im SA, Kim JW, Kim JS, Kim MA, Jordan B, Pickl M, et al. Clinicopathologic characteristics of patients with stage III/IV (M(0)) advanced gastric cancer, according to HER2 status assessed by immunohistochemistry and fluorescence in situ hybridization. Diagn Mol Pathol. 2011;20:94-100.
-
(2011)
Diagn Mol Pathol
, vol.20
, pp. 94-100
-
-
Im, S.A.1
Kim, J.W.2
Kim, J.S.3
Kim, M.A.4
Jordan, B.5
Pickl, M.6
-
30
-
-
79952079704
-
HER2 status in gastro-oesophageal adenocarcinomas assessed by two rabbit monoclonal antibodies (SP3 and 4B5) and two in situ hybridization methods (FISH and SISH)
-
21323962 10.1111/j.1365-2559.2011.03760.x
-
Boers JE, Meeuwissen H, Methorst N. HER2 status in gastro-oesophageal adenocarcinomas assessed by two rabbit monoclonal antibodies (SP3 and 4B5) and two in situ hybridization methods (FISH and SISH). Histopathology. 2011;58:383-94.
-
(2011)
Histopathology
, vol.58
, pp. 383-394
-
-
Boers, J.E.1
Meeuwissen, H.2
Methorst, N.3
-
31
-
-
79960906419
-
Low frequency of HER2 amplification and overexpression in early onset gastric cancer
-
1:CAS:528:DC%2BC3MXnsVSgtrw%3D
-
Moelans CB, Milne AN, Morsink FH, Offerhaus GJ, van Diest PJ. Low frequency of HER2 amplification and overexpression in early onset gastric cancer. Cell Oncol (Dordr). 2011;34:89-95.
-
(2011)
Cell Oncol (Dordr)
, vol.34
, pp. 89-95
-
-
Moelans, C.B.1
Milne, A.N.2
Morsink, F.H.3
Offerhaus, G.J.4
Van Diest, P.J.5
-
32
-
-
62849125361
-
The prognostic significance of the mucin phenotype of gastric adenocarcinoma and its relationship with histologic classifications
-
19148512 10.3892/or-00000337
-
Lee OJ, Kim HJ, Kim JR, Watanabe H. The prognostic significance of the mucin phenotype of gastric adenocarcinoma and its relationship with histologic classifications. Oncol Rep. 2009;21:387-93.
-
(2009)
Oncol Rep
, vol.21
, pp. 387-393
-
-
Lee, O.J.1
Kim, H.J.2
Kim, J.R.3
Watanabe, H.4
-
33
-
-
0030941458
-
P53, the cellular gatekeeper for growth and division
-
DOI 10.1016/S0092-8674(00)81871-1
-
Levine AJ. p53, the cellular gatekeeper for growth and division. Cell. 1997;88:323-31. (Pubitemid 27131374)
-
(1997)
Cell
, vol.88
, Issue.3
, pp. 323-331
-
-
Levine, A.J.1
-
34
-
-
0030866516
-
Lonely no more: P53 finds its kin in a tumor suppressor haven
-
DOI 10.1016/S0092-8674(00)80347-5
-
Oren M. Lonely no more: p53 finds its kin in a tumor suppressor haven. Cell. 1997;90:829-32. (Pubitemid 27381621)
-
(1997)
Cell
, vol.90
, Issue.5
, pp. 829-832
-
-
Oren, M.1
-
35
-
-
33644876397
-
Comparison of HER2 gene amplification assessed by fluorescence in situ hybridization and HER2 protein expression assessed by immunohistochemistry in gastric cancer
-
Yano T, Doi T, Ohtsu A, Boku N, Hashizume K, Nakanishi M, et al. Comparison of HER2 gene amplification assessed by fluorescence in situ hybridization and HER2 protein expression assessed by immunohistochemistry in gastric cancer. Oncol Rep. 2006;15:65-71.
-
(2006)
Oncol Rep.
, vol.15
, pp. 65-71
-
-
Yano, T.1
Doi, T.2
Ohtsu, A.3
Boku, N.4
Hashizume, K.5
Nakanishi, M.6
-
36
-
-
78650783838
-
HER2 testing in gastric cancer
-
21169738 10.1097/PAP.0b013e3182026d72 1:CAS:528:DC%2BC3cXhsFygurbE
-
Albarello L, Pecciarini L, Doglioni C. HER2 testing in gastric cancer. Adv Anat Pathol. 2011;18:53-9.
-
(2011)
Adv Anat Pathol
, vol.18
, pp. 53-59
-
-
Albarello, L.1
Pecciarini, L.2
Doglioni, C.3
|